Mueller, Klaus and Breu, Klaus (1999) 10-alpha-aminoacyl-9(10H)-anthracenones: Inhibition of 12(S)-HETE biosynthesis and HaCaT cell growth. ARCHIV DER PHARMAZIE, 332 (1). pp. 31-35. ISSN 0365-6233, 1521-4184
Full text not available from this repository.Abstract
1,8-Dihydroxy-9(10H)-anthracenones with a 10-alpha-aminoacyl group were synthesized using either a mixed-anhydride coupling method or Boc-protected oxazolidinediones. The novel anthracenones were evaluated as inhibitors of the biosynthesis of 12(S)-hydroxyeicosatetraenoic acid (12(S)-HETE) in epidermal homogenate of mice and for inhibition of the growth of HaCaT keratinocytes. These cells were also tested for their susceptibility for the action of the most potent members of this series on plasma membrane integrity, in order to confirm that inhibition of cell growth is not a result of membrane damage induced by prooxidants released from anthracenones. Hydroxyl-radical generation as measure of the prooxidant potential of the compounds was determined by deoxyribose degradation. The most potent analogues of this series were equally potent as anthralin against 12(S)-HETE biosynthesis and keratinocyte proliferation, while oxygen-radical generation and the resulting damage to cell membrane was strongly reduced as compared to the antipsoriatic drug.
| Item Type: | Article |
|---|---|
| Uncontrolled Keywords: | MODULATED REDOX PROPERTIES; ANTIPSORIATIC ANTHRONES; 12-HYDROXYEICOSATETRAENOIC ACID; ANTIPROLIFERATIVE ACTIVITY; PSORIASIS; 12-LIPOXYGENASE; ANTHRALIN; 5-LIPOXYGENASE; KERATINOCYTES; PROLIFERATION; anthracenones; antiproliferative; antipsoriatic; cytotoxicity; HaCaT cells; 12-lipoxygenase |
| Subjects: | 600 Technology > 615 Pharmacy |
| Divisions: | Chemistry and Pharmacy > Institute of Pharmacy |
| Depositing User: | Dr. Gernot Deinzer |
| Date Deposited: | 29 Nov 2022 09:42 |
| Last Modified: | 29 Nov 2022 09:42 |
| URI: | https://pred.uni-regensburg.de/id/eprint/48609 |
Actions (login required)
 |
View Item |
